Wednesday, 22 November 2017 – VYNOVA Group confirms that the construction of its new state-of-the-art potassium hydroxide (KOH) membrane electrolysis facility in Tessenderlo (Belgium) remains fully on schedule. The project is on track for completion in the second quarter of 2018. The new membrane facility will replace the existing mercury cell room.
· KOH conversion at Tessenderlo site on track for completion in Q2 2018
· Significant expansion of NaOH capacity in Tessenderlo by 2019
· Continued long-term commitment to KOH and NaOH market
“Our new world scale facility will enable us to continue as a reliable partner for our customers and ensure our long-term supply of KOH”, says VYNOVA President Stefan Sommer.
In addition to the KOH conversion project, VYNOVA plans to significantly expand the sodium hydroxide (NaOH) capacity at its Tessenderlo site. This expansion will also create additional capacity of chlorine (Cl2), which will be used for the production of ethylene dichloride (EDC). Project completion is expected by early 2019.
Both investments reconfirm the commitment of VYNOVA, an International Chemical Investors Group (ICIG) company, to the KOH and NaOH markets.
ICIG already owns a successfully converted KOH production facility on the site of Potasse et Produits Chimiques SAS (PPC) in Thann (France). “With the KOH conversion in Tessenderlo, we will further strengthen our leading position as the only membrane producer of KOH with two production sites in Europe”, comments Dr. Achim Riemann, Managing Director of ICIG.
About VYNOVA Group
VYNOVA Group is the chlorovinyls platform of International Chemical Investors Group (ICIG). With a network of five facilities in Europe, VYNOVA Group generates yearly sales in excess of EUR 850 million with more than 1,200 employees. Key products sold, in addition to a specific grade portfolio of suspension PVC (S-PVC), include chlorine (Cl2), vinyl chloride monomer (VCM), ethylene dichloride (EDC), sodium and potassium hydroxide (NaOH, KOH), hydrogen (H2), sodium hypochlorite (NaCIO) and hydrochloric acid (HCl). For more information about VYNOVA Group: www.vynova-group.com.
About International Chemical Investors Group
International Chemical Investors is a privately owned industrial group with sales in excess of EUR 2 billion and more than 6,000 employees worldwide. ICIG is focusing on three main platforms: Pharmaceuticals under the CordenPharma brand, Fine Chemicals under the WeylChem brand and Chlorovinyls under the VYNOVA brand. Since inception in 2004, ICIG has acquired 26 independent chemicals and pharmaceutical businesses in Europe and the United States, all of which have origins in major global chemical or pharmaceutical corporations. For more information about International Chemical Investors Group: www.ic-investors.com.